IL7R and RAG1/2 genes mutations/polymorphisms in patients SCID

Iranian Journal of Allergy, Asthma and Immunology

Volumn 10, Issue 2, 2011, Pages 129-132

  Safaei, Sepideh ^a   Pourpak, Zahra ^a   Moin, Mostafa ^a   Houshmand, Massoud ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

Author keywords

IL7R, RAG1; RAG2; Severe combined immunodeficiency disorder

Indexed keywords

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; GENE; GENE MUTATION; GENE SEQUENCE; GENETIC POLYMORPHISM; GENETIC SCREENING; HUMAN; IL7R GENE; IRAN; POLYMERASE CHAIN REACTION; RAG1 GENE; RAG2 GENE; SEVERE COMBINED IMMUNODEFICIENCY;

DNA-BINDING PROTEINS; HOMEODOMAIN PROTEINS; HUMANS; MUTATION; NUCLEAR PROTEINS; POLYMORPHISM, GENETIC; RECEPTORS, INTERLEUKIN-7; SEVERE COMBINED IMMUNODEFICIENCY;

EID: 79959273109     PISSN: 17351502     EISSN: 17355249     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Fischer A, Hacein-Bey-Abina S, Cavazzana-Calvo M. 20 years of gene therapy for SCID. Nat Immunol 2010; 11(6):457-60.
2. Li AL, Li C, Feng YG, Yuan GH, Wang GM, Hao J, et al. Antileukemic Effect of Interleukin-7-Transduced Bone Marrow Stromal Cells in Mice Following Allogeneic T-Cell-Depleted Bone Marrow Transplantation. Transplant Proc 2005; 37(5):2297-9. (Pubitemid 40956436)
3. Akashi K, Kondo M, Weissman IL. Role of interleukin-7 in T-cell development from hematopoietic stem cells. Immunol. Rev 1999; 165:13-28.
4. Giblin W, Chatterji M, Westfield G, Masud T, Theisen B, Cheng H, et al. Leaky SCID and aberrant DNA rearrangements due to a hypomorphic RAG1 mutation. Blood 2009; 113(13):2965-75.
5. HUGU Gene Nomenclature Committee (HGNC) Database.
6. Lewis SM. The mechanism of V(D)J joining: lessons from molecular, immunological and comparative analyses. Adv Immunol 1994; 56:27-150.
7. Ohm-Laursen L, Nielsen C , Fisker N, Thue Lillevang S, Barington T. Lack of Nonfunctional B-cell Receptor Rearrangements in a Patient with Normal B Cell Numbers Despite Partial RAG1 Deficiency and Atypical SCID/Omenn Syndrome. J Clin Immunol 2008; 28(5):588-92.
8. Noordzij JG, de Bruin-Versteeg S, Verkaik NS, Vossen JM, de Groot R, Bernatowska E, et al. The immunophenotypic and immunogenotypic Bcell differentiation arrest in bone marrow of RAG-deficient SCID patients corresponds to residual recombination activities of mutated RAG proteins. Blood 2002; 100(6):2145-52. (Pubitemid 35001250)
9. McMahan CJ, Sadofsky MJ, Schatz DG. Definition of a large region of RAG1 that is important for coimmunoprecipation of RAG2. J Immunol 1997; 158(5):2202-10. (Pubitemid 127470003)
10. Villa A, Sobacchi C, Notarangelo LD, Bozzi F, Abinun M, Abrahamsen TG, et al. V(D)J recombination defects in lymphocytes due to RAG mutations: severe immunodeficiency with a spectrum of clinical presentations. Blood 2001; 97(1):81-8.
11. Bogue M, Roth DB. Mechanism of V(D)J recombination. Curr Opin Immunol 2002; 8(2):175-80.
12. Kalman L, Lindegren ML, Kobrynski L, Vogt R, Hannon H, Howard JT, et al. Mutations in genes required for T-cell development: IL7R, CD45, IL2RG, JAK3, RAG1, RAG2, ARTEMIS, and ADA and severe combined immunodeficiency. Genet Med 2004; 6(1):16-26.
13. Sadofsky MJ, Hesse JE, van Gent DC, Gellert M. RAG-1 mutations that affect the target specificity of V (D) j recombination: a possible direct role of RAG-1 in site recognition. Genes Dev 1995; 9(17):2193-9
14. McMahan CJ, Difilippantonio MJ, Rao N, Spanopoulou E, Schatz DG. A basic motif in the N-terminal region of RAG1 enhances V(D)J recombination activity. Mol Cell Biol 1997; 17(8):4544-52. (Pubitemid 27318131)
15. Roman CA, Cherry ST, Baltimore D. Complementation of V(D)J Recombination Deficiency in RAG-1-/- B Cells Reveals a Requirement for Novel Elements in the N-Terminus of RAG-1. Immunity 1997; 7(1):13-24.
16. Sadofsky MJ, Hesse JE, McBlane JF, Gellert M. Expression and V(D)J recombination activity of mutated RAG-1 proteins. Nucleic Acids Res 1994; 22(3):550.
17. Puel A, Ziegler SF, Buckley RH, Leonard WJ. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998; 20(4):394-7. (Pubitemid 28541642)